La emblemática legislación del presupuesto del presidente Donald Trump castigaría a 14 estados que ofrecen cobertura de salud a personas que viven en el país sin papeles. Estos estados, la mayoría liderados por demócratas, dan seguro médico a algunos inmigrantes de bajos ingresos —a menudo niños—, independientemente de su estatus migratorio. Defensores argumentan que la…
As real-time inference overtakes training-centric approaches, a pivotal question emerges: how can the human element remain central in an increasingly autonomous ecosystem? The post The Future of AI in Healthcare Demands Transparency, Trust, and Human-Centered Design appeared first on MedCity News.
While prior authorization has made many headlines over the past year, concurrent review has not. Yet missteps in both processes leave hospitals in danger of not getting paid, which can result in higher costs being passed down to patients. The post What is Concurrent Review? appeared first on MedCity News.
President Donald Trump’s signature budget legislation would punish 14 states that offer health coverage to people in the U.S. without authorization. The states, most of them Democratic-led, provide insurance to some low-income immigrants — often children — regardless of their legal status. Advocates argue the policy is both humane and ultimately cost-saving. But the federal…
Larry Saltzman has blood cancer. He’s also a retired doctor, so he knows getting covid-19 could be dangerous for him — his underlying illness puts him at high risk of serious complications and death. To avoid getting sick, he stays away from large gatherings, and he’s comforted knowing healthy people who get boosters protect him…
Virtual solutions for depression and anxiety can lead to clinically meaningful outcomes, but certain pricing models may increase costs for employers and health plans, according to the Peterson Health Technology Institute. The post PHTI: Digital Mental Health Solutions Work, But Can Be Costly appeared first on MedCity News.
GSK drug Nucala has expanded its FDA-approved uses to include maintenance treatment of chronic obstructive pulmonary disease that’s driven by eosinophils, a type of immune cell. The antibody drug will compete against the blockbuster Sanofi product Dupixent, which expanded its FDA approval to COPD last year. The post GSK Inflammation Drug Lands New FDA Nod…
Startup finalists competed in four tracks: biopharma; devices and diagnostics; health tech aimed at consumers and self-insured employers; and health tech aimed at payers and providers. Investor judges in each track selected the winners. The post Who Won MedCity INVEST Pitch Perfect? appeared first on MedCity News.
The Alzheimer’s disease drugs that have reached the market in the past two years are antibodies designed to break up amyloid plaques. Vigil Neuroscience brings to Sanofi a different approach: an oral small molecule designed to activate microglia, immune cells that play a key role in brain health. The post Sanofi’s Neuro Pipeline Expands to…
Beyond the human cost, workplace violence carries significant economic consequences for healthcare institutions. Addressing this issue through virtual technology represents not just an ethical imperative but a financial one. The post Hidden in Plain Sight: How Existing Hospital Technology Can Prevent Workplace Violence appeared first on MedCity News.